Stock Quote

Walgreen Co (WAG) (NYSE Arca)
As of  1:34pm EST
39.37USD
Price Change
+0.40
Percent Change
+1.03%
 
$39.37
1:34pm EST
+1.03%
$38.97
$39.15
2,823,101
$39.80
$39.12
$40.69
$21.39
0.76
6,641,400

Research Another Stock: Symbol Look-up
AmEx to buy Revolution Money payment platform
Wednesday, 18 Nov 2009 11:52am EST 
UPDATE 3-AmEx to buy Revolution Money payment platform
Wednesday, 18 Nov 2009 11:50am EST 
Walmart set for "extremely competitive" holiday
Thursday, 12 Nov 2009 02:43pm EST 
Walmart set for 'extremely competitive' holiday
Thursday, 12 Nov 2009 02:31pm EST 
CVS Caremark must change pitch to save merger
Friday, 6 Nov 2009 02:03pm EST 
Stephen Mandel's Lone Pine Capital Q3 Portfolio: A Basket Full of Apple
Thursday, 19 Nov 2009 07:55am EST(Seeking Alpha) 
Cramer's 'Mad Money' Follow-Up: Nov. 16
Monday, 16 Nov 2009 05:13pm EST(The Street) 
Cramer's Lightning Round - Getting Chicken About Tyson (11/13/09)
Sunday, 15 Nov 2009 05:43am EST(Seeking Alpha) 
'Mad Money Lightning Round': Hold on to BP
Friday, 13 Nov 2009 07:24pm EST(The Street) 
Cramer's 'Mad Money' Recap: The Better-Than-Expected Game (Final)
Friday, 13 Nov 2009 06:35pm EST(The Street) 
 
Name Current Position Compensation
McNally, Alan Chairman of the Board --
Walgreen, Charles Chairman Emeritus 1,557,890
Wasson, Gregory President, Chief Executive Officer, Director 2,621,650

Profile

Walgreen Co. (Walgreens) is engaged in retail drugstore business. As of August 31, 2009, the Company operated 7,496 locations in 50 states, the District of Columbia, Puerto Rico and Guam. During the fiscal year ended August 30, 2009 (fiscal 2009), the Company opened or acquired 691 locations. Total... Full Description

Company Address

Walgreen Co
200 Wilmot Road
Deerfield   IL   60015
P: +1847.9142500
F: +1847.9142804

Analyst Research

Performance of Key Competitors

Company Price Change
Wal-Mart Stores, Inc. $54.79 +0.51
CVS Caremark Corporation $31.99 +0.35
Rite Aid Corporation $1.32 +0.04
  WAG Industry
P/E(TTM) 19.25 2.54
P/S(TTM) 0.61 0.07
ROI(TTM) 11.75 1.33
ROE(TTM) 14.73 2.03
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.74
EPS Est. (Current Year) 1.98
Total Revenue $15,703.00M
Net Income $436.00M
EPS $0.44